Cleerly LABS vs AI-CVD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cleerly LABS

by Cleerly

AI-CVD

by HeartLung AI

AI Verdict

Cleerly LABS is designed for comprehensive analysis of dedicated CCTA scans to characterize coronary atherosclerosis and stenosis for personalized heart disease management. In contrast, AI-CVD focuses on opportunistic screening for cardiovascular and multisystem risks by leveraging existing chest and abdominal CT scans without requiring additional imaging. Therefore, Cleerly is suited for detailed coronary assessment, while AI-CVD is for broader, incidental risk detection.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary goal is a detailed and comprehensive assessment of coronary artery disease using a dedicated coronary CT angiography (CCTA) scan. This tool is ideal for precisely quantifying plaque volume and type, detecting stenosis, and tracking disease progression to inform personalized treatment strategies for patients with suspected or known CAD.

View Cleerly LABS →

Choose AI-CVD if…

Choose AI-CVD if you aim to opportunistically screen for cardiovascular and multisystem disease risks using existing chest or abdominal CT scans. This platform is best suited for leveraging routine imaging to identify hidden health concerns like coronary artery calcium or aortic calcification without requiring additional radiation, contrast, or workflow disruption.

View AI-CVD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cleerly LABS	AI-CVD
Pricing	Per analysis	Unknown
Deployment	Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer.	Unknown
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cleerly LABS	AI-CVD
Tool Name	Cleerly LABS	AI-CVD
Company	Cleerly	HeartLung Corporation
Primary Use Case / Description Summary	AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management.	FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks.
Core Imaging Modality / Data Source	Coronary CT angiography (CCTA)	Existing CT scans (chest and abdominal CT scans)
Key Feature: Comprehensive Plaque Analysis	Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Tracking disease progression over time.	Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis.
Key Feature: Opportunistic Screening	Not specified	Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption.

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and AI-CVD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What type of imaging data is required for each tool?

Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) scans. In contrast, AI-CVD performs opportunistic screening for cardiovascular and multisystem diseases using existing chest and abdominal CT scans, without requiring additional imaging.

What are the primary clinical insights and measurements provided by each tool?

Cleerly LABS offers AI-powered CCTA image analysis for comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, and ischemia detection with its ISCHEMIA module. AI-CVD provides automated CT-derived measurements such as Coronary Artery Calcium (CAC) scoring, aortic and mitral valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, and aorta and pulmonary artery sizing.

How do the workflow integration and patient impact differ between Cleerly LABS and AI-CVD?

Cleerly LABS requires a dedicated CCTA scan and integrates with PACS, RIS, and EHR via an on-site Cleerly Proxy. AI-CVD utilizes existing CT scans for opportunistic screening, aiming for no additional imaging, radiation, contrast, or workflow disruption.

Can either tool be used for tracking disease progression or personalized risk assessment over time?

Cleerly LABS explicitly lists personalized heart disease risk assessment and tracking disease progression over time as key features. AI-CVD focuses on opportunistic screening and early detection from existing scans, with its listed features not specifically detailing disease progression tracking over time.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly LABS or AI-CVD

Backers

Who funded each tool's parent company.